ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
196 hedge funds and large institutions have $3.49B invested in ChemoCentryx, Inc. in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 79 increasing their positions, 65 reducing their positions, and 36 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 65
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
14% more capital invested
Capital invested by funds: $3.06B → $3.49B (+$429M)
4% less funds holding
Funds holding: 204 → 196 (-8)
19% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 36
49% less call options, than puts
Call options by funds: $21.2M | Put options by funds: $41.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$43.3M |
| 2 |
AG
Artal Group
Luxembourg
|
+$37.2M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
+$30.5M |
| 4 |
BlackRock
New York
|
+$19M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$16.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$37.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$31.8M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$22.1M |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$19.4M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$18.9M |
CCXI Hedge Fund Activity: Q4 2020 in Review
196 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2020, worth a combined $3.49B — up 14% from $3.06B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of CCXI and 29 opened new positions — a net loss of 7 holders — while 65 trimmed existing stakes and 79 added.
The largest buyer was Avidity Partners Management, opening a new position worth an estimated $43.3M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $37.2M sold.
- 196 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2020, down from 204 in Q3 2020.
- Funds reported $3.49B of ChemoCentryx, Inc. stock for Q4 2020, up 14% quarter-over-quarter.
- 29 funds opened new ChemoCentryx, Inc. positions in Q4 2020 and 36 closed out, a net change of -7 holders.
- The largest ChemoCentryx, Inc. buyer in Q4 2020 was Avidity Partners Management, an estimated $43.3M added.
- The largest ChemoCentryx, Inc. seller in Q4 2020 was Point72 Asset Management, an estimated $37.2M sold.
Based on aggregated 13F filings for Q4 2020.